B cell stimulatory factor 1 (interleukin 4) is sufficient for the proliferation and differentiation of lectin-stimulated cytolytic T lymphocyte precursors by unknown
B CELL STIMULATORY FACTOR 1 (INTERLEUKIN 4)
IS SUFFICIENT FOR THE PROLIFERATION AND
DIFFERENTIATION OF LECTIN-STIMULATED
CYTOLYTIC T LYMPHOCYTE PRECURSORS
BY JOHN D. PFEIFER, DOUGLAS T. McKENZIE, SUSAN L. SWAIN, AND
RICHARD W. DUTTON
From theDepartment ofBiology, University ofCalifornia, San Diego,
Lafolla, California 92093
The in vitro generation of splenic CTL requires both proliferation and
differentiation of inactive precursors. Beyond the requirement for antigen or
mitogenic lectin, the details of CTL induction remain controversial. Accessory
cells are involved (1) and Th cells provide soluble mediators. IL-2 promotes the
proliferation of CTL precursors (2), but various CTL differentiation factors (3-
5) may also have a role. Recent reports (6, 7) have demonstrated that IL-2 alone
is sufficient for proliferation and differentiation of lectin or alloantigen-stimu-
lated CTL precursors into fully active CTL.
B cell stimulatory factor 1 (BSF-1/IL-4),' a Th cell-derived lymphokine with
a well-characterized spectrum of activities on B cells, has recently been shown to
exhibit a number of activities on T cells as well. Thus, IL-4 has been shown to
support the proliferation of long-term T cell lines (8, 9), to be a potent costim-
ulant for normal resting T lymphocytes (10), and to mediate the autocrine
growth of Th cell lines after antigenic stimulation (11) . In this report we
demonstrate that purified IL-4 is also sufficient to stimulate both the proliferation
and differentiation of splenic CTL precursors stimulated with the mitogenic
lectin Con A .
Materials and Methods
Animals. (C57BL/6 X DBA/2)F, hybrids were raised in our colony from breeding
pairs originally obtained from The Jackson Laboratory, Bar Harbor, ME. Mice were used
as spleen donors at 2-3 mo of age.
Monoclonal Antibodies.
￿
The cell line making anti-L3T4, LICR.LAU.RL172.4, was a
kind gift of Dr. Susan Webb (Scripp Clinic and Research Foundation, La Jolla, CA), and
the cell line producing anti-IL-2-R, 7D4, was a kind gift of Dr. Tom Malek (Univ. of
Miami, School of Medicine, Miami, FL). The cell line producing the anti-lab'd was a
generous gift of Dr. Sue Tonkonogy (School of Veterinary Medicine, North Carolina
State University, Raleigh, NC). Antibodies from the above lines were obtained from
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' Abbreviation used in this paper:
￿
BSF-I, Bcell stimulatory factor 1/IL-4.
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ascites collected from pristane-injectedmice inoculated with tumorcells. The cell produc-
ing the mAb 11 B11 to IL-4 was obtained from Maureen Howard (DNAX Research
Institute, Palo Alto, CA); culture supernatant from the 11B11 hybridoma, pressure
concentrated and partially purified on an HPLC ion-exchange column, served as the
source of antibody.
Factors.
￿
rIL-2 (human) was obtained from Cetus Corp., Emeryville, CA. IL-4/B cell
stimulatory factor 1 (BSF-1) was purified to homogeneity from the serum-free culture
supernatants of the cell line D10.G4.1, a conalbumin-specific la'-restricted T cell line of
the TH2 type (12, 13). The DIO cells were stimulated with Con A for 48 h, and crude
culture supernatants absorbed onto and eluted from controlled-pore glass according to
the method of Henderson et al. (14). BSF-1 containing material eluted from controlled-
pore glass was dialyzed against 10 mM Tris, pH 7.0, and applied to a 250 X 10 cm high-
pressure ion-exchange column (SynChrom, Inc., Linden, IN). The column was eluted
with a 0-250-mM sodium phosphate, pH 7.0, gradient. The active fractionswere pooled,
concentrated by ultrafiltration, and applied to a Vydac C4 reverse-phase HPLC column
(The Separations Group, Hesperia, CA) equilibrated in 0.1 % TFA, 30% acetonitrile. The
column was developed with a linear gradient of 30-80% acetonitrile in 0.1% TFA over
80 min. The IL-4 activity wasrecoveredat ^-39%acetonitrile.Thepurified IL-4 contained
a single major protein on SDS-PAGE and contained no detectable IL-1, IL-2, IL-3, or
BCGF-II/IL-5, (McKenzie, D. T., H. I. Filutowicz, S. L. Swain, and R. W. Dutton,
manuscript submitted for publication). Recombinant IL-4 used in some experiments was
obtained from DNAX Research Institute.
1 U of IL-4 is defined as the amount of IL-4 needed for half-maximal stimulation of
[]25I]UdR incorporation by resting B cells stimulated with rat anti-mouse IgM mAb
obtained from the supernatant of the hybridoma Bet2 (15). Thehalf-maximal stimulation
of proliferation of the cloned IL-2-dependent T cell line NK (16) requires 0.03'U/ml of
IL-4.
Lyt-2+ Subset Isolation.
￿
Splenic T lymphocytes were isolated as described by Julius et
al. (17). The nylon column-purifiedcells recovered from this procedurewere >90% Thy-
1.2+. Cells were incubated for 30 min on ice with the anti-L3T4 mAb RL172.4 and the
anti-lab/d mAb D3.137, followed by incubation twice with guinea pig and rabbit comple-
ment for 30 min at 37 °C. In control experiments, thymocytes prepared in this way were
<1% L3T4+ as determined by flow cytofluorometry.
Cell Culture.
￿
5 X 104 Ia,L3T4- splenic T cells isolated as described above were
stimulated with IL-2 or IL-4 in the presence of 1 ug/ml Con A. Cells were cultured in U-
bottomed microtiter plates (No. 3799; Costar, Cambridge, MA) in RPMI 1640 supple-
mented with 5% FCS, 200 IU/ml penicillin, 200 mg/ml streptomycin, 4 mM glutamine,
50 mM 2-ME and 25 mM Hepes. Microcultures contained a final volume of 200 A1
medium per well, andwere incubated at 37°C in a humidified 5% C02 in air atmosphere.
Assay for Cytolytic Activity.
￿
Cells were assayed for cytolytic activity on day 5 in the
presence of 10 wg/ml Con A. Effector cells were incubatedfor 4 h with 2'0005'Cr-labeled
P815 tumor targets in 96-wellV-bottomed microtiter plates (No. 3896, Costar).To obtain
sufficient numbers of cells for effector titrations, cells from replicate microculture wells
were pooled. The apparent specific lysis was calculated as 100 X [(experimental release -
spontaneous release)/(total release - spontaneous release)] in which spontaneous release
is thecpm releasein theabsence of effector cells and total release is determined by adding
Triton X-100 to a final concentration of 0.4%.
Assayfor Cell Proliferation.
￿
At 24-h intervals after initiation of culture, 50 A1 of cell
suspension from each of triplicate microcultures was transferred to 96-well flat-bottomed
microtiter plates (No. 3596, Costar), to which [`25I]UdR was immediately added. ['2sI]-
UdR incorporation was determined after incubation foran additional 24 h.
Results
Preparation ofIL-4/BSF-1.
￿
The purified IL-4 used for these studies contained
a single protein on SDS-PAGE and contained no detectable IL-I, IL-2, IL-3, or1466
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FIGURE 1 .
￿
Proliferative response of lectin-stimulated Lyt-2' splenic T cells to IL-4 (A) or
IL-2 (B). At 24-h intervals, [1251]UdR was added to 50 A1 of cell suspension removed from
each of triplicate microcultures initiated with the indicated concentration of lymphokine. [1251]UdR incorporation was determined after incubation for an additional 24 h. All cultures
contained Con A at 1 ug/ml. 7134 ascites was used at a final concentration of 1:3,200. Error
bars represent ±1 SD. See Materials and Methods for experimental details. (A) (0) 15 U/ml
IL-4; (0) 5 U/ml IL-4; (/) 1.5 U/ml IL-4; (p) 15 U/ml IL-4 + 7D4 ascites; (O) 5 U/ml IL-4
+ 7D4 ascites; (El) 1.5 U/ml IL-4 + 7D4 ascites; (A) Con A alone. (B) (p) 90 U/ml IL-2; (0)
30 U/ml IL-2; (A) 10 U/ml IL-2; (/) 90 U/ml IL-2 + 7D4 ascites; (O) 30 U/ml IL-2 + 7D4
ascites; (A) 10 U/ml IL-2 + 7134 ascites.
BCGF-II/IL-5 activity (McKenzie, D. T., H. I. Filutowicz, S. L. Swain, and R.
W. Dutton, manuscript submitted for publication). The sample had an approxi-
mate specific activity of 16 U/ng and at a dilution of 1:2 x 104 exhibited a half-
maximal stimulation of proliferation of resting B cells stimulated with rat mono-
clonal anti-mouse IgM antibody (data not shown).
Lectin andIL-4 Will Induce the Proliferation ofSplenicLyt-2+ CTLPrecursors.
￿
As
is shown in Fig. I A, addition of Con A and IL-4 together results in a vigorous
proliferative response by splenic Lyt-2+ T cells, a proliferative response that has
not yet reached a plateau by day 5. At the concentrations used here, Con A
alone or IL-4 alone (data not shown) does not cause significant proliferation . As
a positive control, Fig. 1 B demonstrates that IL-2 and Con A will also cause a
strong proliferative response of Lyt-2+ splenic T cells, as previously reported (6).
Fig. 1 B demonstrates that addition of the anti-IL-2-R antibody at high concen-
tration results in ^-75% inhibition of the proliferative response to Con A and IL-
2 at the highest concentration of IL-2 used, and the complete inhibition of the
proliferative response at lower concentrations of IL-2 . Fig. 1A shows thatPFEIFER ET AL.
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addition of anti-IL-2-R blocking antibody results in only a slight, statistically
insignificant inhibition of the proliferative response to IL-4 plus Con A.
Lectin and IL-4 Will Induce the Generation of Cytolytic Activity in Splenic Lyt-2+
CTL Precursors. Fig. 2A demonstrates that after culture for 5 d with IL-4 and
Con A, Splenic Lyt-2+ cells have developed marked cytolytic activity. Culture
with Con A alone does not induce the generation of cytolytic cells (data not
shown), although culture with IL-4 does induce a small but reproducible gener-
ation ofcytolytic activity at high concentrations ofthe lymphokine. In additional
experiments (Fig. 2D), similar responses were obtained using rIL-4 and Con A.
Fig. 2B shows the cytolytic activity of cultures of Lyt-2+ Splenic T cells
stimulated with IL-2 plus Con A. Despite the equivalent proliferative response
ofcells stimulated with IL-2 plus Con A and cells stimulated with IL-4 plus Con
A, it is noteworthy that 15 U/ml IL-4 induces a markedly higher level ofcytolytic
activity per cell than 90 U/ml IL-2. Higher cytolytic cell responseswere obtained
with higher doses of rIL-2 (data not shown).
Addition of the mAb, 7D4, at high concentration inhibits the generation of
cytolytically active cells by IL-2 plus Con A, as shown in Fig. 2B, but has no
significanteffect on the generation ofcytolytically active cells in cultures induced
with IL-4 plus Con A, as shown in Fig. 2A. Fig. 2C demonstrates that the IL-4-
dependent responses, but not the IL-2-dependent responses, are blocked by
11B11, the mAb to IL-4. The cytolytic activity of the effector cells on day 5 was
completely abolished by treatment with anti-Lyt-2 and complement before assay,
demonstrating that the effector CTL are CD8+ (data not shown).
Discussion
BSF-1/IL-4 has been shown to exhibit a number ofactivities on various Tcell
populations in addition to its activities on B cells. IL-4 will support the prolifer-
ation of long-term T cell lines (8, 9), is able to mediate the autocrine growth of
some helper T cell lines after antigenic stimulation (11), and is a potent costi-
mulant for normal resting T lymphocytes (10). A recent report (18) also dem-
onstrates that IL-4 enhances the CTL response to alloantigen within mixed
lymphocyte cultures.
We demonstrate here that Lyt-2+ Splenic T cells will proliferate to IL-4
together with the mitogenic lectin Con A, and that the proliferating Lyt-2+ cells
will differentiate into CTL. The recent report (10) that both the L3T4+ and
Lyt-2+ mesenteric lymph node T cell populations proliferate vigorously to IL-4
together with PMA is in agreement with our results.
Previous reports (6, 7) have demonstrated that IL-2 alone is sufficient for the
proliferation anddifferentiation oflectin- orantigen-stimulated CTL precursors .
These results, when coupled with the costimulatory effects of IL-4 on Th cells
(10, 11) and the presence of an IL-2-producing T cell subset within the Lyt-2+
population (19, 20), made it necessary to rule out any contribution by endoge-
nously produced IL-2 to the proliferation and differentiation of cytolytically
active cells observed in the cultures. The lack of any significant effect by the
blocking anti-IL-2 (21, 22) receptor antibody argues that the stimulatory effects
of the purified IL-4 are a property ofthe IL-4 itself.
It was noteworthy that levels of IL-4 that support a significantly smaller1468
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GL yproliferative response than observed with a given concentration of IL-2 are more
efficacious in stimulating the differentiation of Lyt-2' cells into mature cytolyti-
cally active cells. The ability of IL-4 to drive differentiation of Lyt-2' cells into
mature CTL is so marked that we propose a model in which IL-2 is primarily
responsible for CTL precursor proliferation but in which IL-4 is the lymphokine
primarily responsible for CTL precursor differentiation. This suggests that
although Thl or Th2 cells (as defined by Mossman et al. in reference 13) can
independently produce a lymphokine that is sufficient for mature CTL genera-
tion, the combined action of the lymphokines produced by Th l and Th2 cells
may be most efficient for CTL generation.
Finally it will be of interest to establish the relationship of IL-4 to other
previously described CTL differentiation factors (3-5).
Summary
In this report, we demonstrate that IL-4 is sufficient to stimulate both the
proliferation and differentiation of Lyt-2+, la- splenic CTL precursors stimulated
with the mitogenic lectin Con A. The response to IL-4 and Con A was not
dependent on a putative endogenous production of IL-2 within the cultures, as
demonstrated by an absence of an inhibitory effect by an anti-IL-2-R blocking
mAb. Our results indicate that IL-2 and IL-4 can support an equivalent prolif-
erative response by lectin-stimulated Lyt-2' T lymphocytes, while IL-4 is more
efficacious in stimulating their differentiation into mature cytolytically active
cells.
We thank Terry Aaron for her excellent secretarial assistance.
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